Mona H. Ibrahim

Identification of Novel Cyanopyridones and Pyrido[2,3-d]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies

Tarfah Al‐Warhi, Al-Aliaa M. Sallam, Loah R. Hemeda et al. · Pharmaceuticals · 2022 · 74 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Apoptosis: A target for anticancer therapy with novel cyanopyridines

Magda M. F. Ismail, Amel M. Farrag, Marwa F. Harras et al. · Bioorganic Chemistry · 2019 · 54 citations

Life Sciences, Oncology, Pharmacology +14

SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population

Ali Mir, Montaha Almudhry, Fouad Alghamdi et al. · Human Genetics · 2021 · 34 citations

Life Sciences, Genetics, Molecular Genetics +15

New cyanopyridine-based scaffold as PIM-1 inhibitors and apoptotic inducers: Synthesis and SARs study

Amel M. Farrag, Mona H. Ibrahim, Ahmed B. M. Mehany et al. · Bioorganic Chemistry · 2020 · 30 citations

Pharmacy, Medicinal Chemistry, Pharmacology +6

The Effect of a Tribulus-Based Formulation in Alleviating Cholinergic System Impairment and Scopolamine-Induced Memory Loss in Zebrafish (Danio rerio): Insights from Molecular Docking and In Vitro/In Vivo Approaches

Salwa Bouabdallah, Ion Brinza, Răzvan Ştefan Boiangiu et al. · Pharmaceuticals · 2024 · 28 citations · Full text

Medicine, Neuroscience, Pharmacology +17